Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

RHAPSODY, Biomarkers and Novel Clinical Trial design in type 2 diabetes (T2D) and prediabetes

Adams, Rachel ; Daly, Nicole ; Robertson, Elizabeth and Giordano, Giuseppe N. LU (2021) In Endocrinology, Diabetes and Metabolism 4(2).
Abstract

Developing a novel therapeutic product for the treatment of type 2 diabetes (T2D) is a long, resource-intensive process. Novel biomarkers could potentially aid clinical trial design by shortening clinical trials or enabling better prediction of at-risk populations and/or disease progression. Novel clinical trial designs could lead to reduced costs of development and less burden to patients, due to shorter trial duration, and/or less burdensome assessments.

Please use this url to cite or link to this publication:
author
; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
biomarkers, disease progression, novel clinical trial design, prediabetes, type 2 diabetes mellitus
in
Endocrinology, Diabetes and Metabolism
volume
4
issue
2
publisher
John Wiley & Sons Inc.
external identifiers
  • pmid:33855210
  • scopus:85097246012
ISSN
2398-9238
DOI
10.1002/edm2.207
language
English
LU publication?
yes
id
89dd3759-5a87-403a-96aa-308079027209
date added to LUP
2020-12-15 14:45:26
date last changed
2024-03-20 21:53:28
@article{89dd3759-5a87-403a-96aa-308079027209,
  abstract     = {{<p>Developing a novel therapeutic product for the treatment of type 2 diabetes (T2D) is a long, resource-intensive process. Novel biomarkers could potentially aid clinical trial design by shortening clinical trials or enabling better prediction of at-risk populations and/or disease progression. Novel clinical trial designs could lead to reduced costs of development and less burden to patients, due to shorter trial duration, and/or less burdensome assessments.</p>}},
  author       = {{Adams, Rachel and Daly, Nicole and Robertson, Elizabeth and Giordano, Giuseppe N.}},
  issn         = {{2398-9238}},
  keywords     = {{biomarkers; disease progression; novel clinical trial design; prediabetes; type 2 diabetes mellitus}},
  language     = {{eng}},
  number       = {{2}},
  publisher    = {{John Wiley & Sons Inc.}},
  series       = {{Endocrinology, Diabetes and Metabolism}},
  title        = {{RHAPSODY, Biomarkers and Novel Clinical Trial design in type 2 diabetes (T2D) and prediabetes}},
  url          = {{http://dx.doi.org/10.1002/edm2.207}},
  doi          = {{10.1002/edm2.207}},
  volume       = {{4}},
  year         = {{2021}},
}